---
figid: PMC7103059__MI2020-3830212.003
figlink: pmc/articles/PMC7103059/figure/fig3/
number: Figure 3
caption: 'Signaling pathways in osteoclast activation. During RA pathogenesis, antigen-presenting
  cells after uptake of an autoantigen or pathogenic molecules process and present
  antigenic determinants on their cell surface in conjunction with arthritis-permissible
  HLA/MHC class II molecules, which activate differentiation of T cells into different
  subphenotypes. The activated T cells secrete various cytokines like IL-6, IL-7,
  IL-10, IL-12, IL-17, IL-23, and IFN-γ. These cytokines modulate macrophages to secrete
  various pro- and/or anti-inflammatory cytokines and other inflammatory mediators.
  Upon exposure to the inflammatory cytokines, fibroblast-like synoviocytes express
  RANKL, which binds with its receptor (RANK) present on the cell surface of activated
  macrophages initiating the RANK/RANKL pathway through TRAF 2, 5, and 6 proteins,
  which leads to the activation of downstream NF-κB, MAPK, NFATc1, and Src signaling
  cascades. These factors after translocation initiate the expression of genes like
  TRAP, CtsK, and MMP-9 in the nucleus, which promote osteoclastogenesis and bone
  resorption. TLR: toll-like receptor; TCR: T cell receptor; CtsK: cathepsin K; I-κB:
  inhibitor of the NF-κB transcription factor; IL: interleukin; IFN-γ: interferon
  gamma; MAPK: mitogen-activated protein kinase; MHC II: major histocompatibility
  complex II; MITF: microphthalmia-associated transcription factor; MMP 9: matrix
  metalloproteinase 9; NFATc1: nuclear factor of activated T cells, calcineurin-dependent
  1; NF-κB: nuclear factor kappa B; p50 and p65: REL-associated proteins (also called
  NF-κB1 and RelA) involved in NF-κB heterodimer formation and nuclear translocation
  and activation; RANK: receptor activator of nuclear factor-κB; RANKL: receptor activator
  of nuclear factor κB ligand; Src: intracellular non-receptor tyrosine kinase; TRAF:
  TNF receptor-associated factor; TRAP: tartrate-resistant acid phosphatase. c-Jun
  and c-Fos form the early response transcription factor, AP-1.'
pmcid: PMC7103059
papertitle: Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid
  Arthritis.
reftext: Qinghua Fang, et al. Mediators Inflamm. 2020;2020:3830212.
pmc_ranked_result_index: '94001'
pathway_score: 0.9339876
filename: MI2020-3830212.003.jpg
figtitle: Signaling pathways in osteoclast activation
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7103059__MI2020-3830212.003.html
  '@type': Dataset
  description: 'Signaling pathways in osteoclast activation. During RA pathogenesis,
    antigen-presenting cells after uptake of an autoantigen or pathogenic molecules
    process and present antigenic determinants on their cell surface in conjunction
    with arthritis-permissible HLA/MHC class II molecules, which activate differentiation
    of T cells into different subphenotypes. The activated T cells secrete various
    cytokines like IL-6, IL-7, IL-10, IL-12, IL-17, IL-23, and IFN-γ. These cytokines
    modulate macrophages to secrete various pro- and/or anti-inflammatory cytokines
    and other inflammatory mediators. Upon exposure to the inflammatory cytokines,
    fibroblast-like synoviocytes express RANKL, which binds with its receptor (RANK)
    present on the cell surface of activated macrophages initiating the RANK/RANKL
    pathway through TRAF 2, 5, and 6 proteins, which leads to the activation of downstream
    NF-κB, MAPK, NFATc1, and Src signaling cascades. These factors after translocation
    initiate the expression of genes like TRAP, CtsK, and MMP-9 in the nucleus, which
    promote osteoclastogenesis and bone resorption. TLR: toll-like receptor; TCR:
    T cell receptor; CtsK: cathepsin K; I-κB: inhibitor of the NF-κB transcription
    factor; IL: interleukin; IFN-γ: interferon gamma; MAPK: mitogen-activated protein
    kinase; MHC II: major histocompatibility complex II; MITF: microphthalmia-associated
    transcription factor; MMP 9: matrix metalloproteinase 9; NFATc1: nuclear factor
    of activated T cells, calcineurin-dependent 1; NF-κB: nuclear factor kappa B;
    p50 and p65: REL-associated proteins (also called NF-κB1 and RelA) involved in
    NF-κB heterodimer formation and nuclear translocation and activation; RANK: receptor
    activator of nuclear factor-κB; RANKL: receptor activator of nuclear factor κB
    ligand; Src: intracellular non-receptor tyrosine kinase; TRAF: TNF receptor-associated
    factor; TRAP: tartrate-resistant acid phosphatase. c-Jun and c-Fos form the early
    response transcription factor, AP-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - CD86
  - CD80
  - TNFSF11
  - CD28
  - TRA
  - TRB
  - TRD
  - TRG
  - TNF
  - IL6
  - IL7
  - IL1A
  - IL1B
  - IL12A
  - IL12B
  - IL23A
  - TRAF2
  - TRAF6
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - SRC
  - MMP9
  - MITF
  - JUN
  - FOS
  - TCR
genes:
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: CD80/CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CD80/CD86
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: RANKL.
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: -CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-7
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: TRAP,MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: -Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases: []
---
